hotspot -WSS

hotspot

author：comprehensive 2025-09-30 01:12:25 - browse：231

Alphabet’s life sciences company Verily has scored its first Centers for Disease Control and Prevention contract, a high profile job leaders hope will boost its brand in public health as well as its nascent wastewater surveillance business, executives told STAT.

Under the up-to-five year, $38 million contract, Verily will collect samples from hundreds of wastewater treatment centers across the country, analyze them for Covid-19 and the mpox virus at its South San Francisco lab, and return the data to CDC within 36 hours of collecting the samples. The contract is limited to those two pathogens but the company is prepared to analyze more if needed, leaders said.

The contract comes as Verily struggles to turn a profit among various disparate health care offerings, like value-based care analytics for health systems, clinical trial software and even an in-person substance use rehabilitation center in Ohio. Despite several prominent hires and a vast number of projects, the company has yet to forge a sustainable business.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Grail is spending more than ever lobbying Congress

WSS

FDA advisers vote against ALS treatment from BrainStorm

Bacterial infection may be ‘key event’ in endometriosis, study says

Address the ethical violations that led to 'Three Identical Strangers'

Bacterial infection may be ‘key event’ in endometriosis, study says

Data show record exodus of life scientists from academia

Address the ethical violations that led to 'Three Identical Strangers'

hotspot

hotspot

entertainment

New air purifier tech could be key to improving indoor air quality

Australia's humpback populations rebound raising hopes of marine scientists

The cancer drug shortage isn’t new — and neither are the solutions

Grail is spending more than ever lobbying Congress

As demand for Covid shots wanes, Moderna seeks its next success

Researchers use wearables data and AI to predict preterm birth risk

Trump demands the U.S. pay no more for drugs than other countries … again

Did the public have the right to know Arthur Ashe had AIDS?

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Option Care buys Amedisys in $3.6 billion home care deal

entertainment

Health tech startups drop sharply from 2021 highs

Would Medicare drug price negotiations stall in a shutdown?

7 people shot in DC, police say

Why is France rioting? What to know about the fatal police shooting of Nahel M

FDA seeks to regulate lab

Ionis has late

leisure time

hotspot

entertainment

focus